The Animal Blood Product Market is being driven by Increasing sophistication of veterinary medicine and humanization of companion animals
The Animal Blood Product Market is expected to grow at a CAGR of 7.3% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 1914.7 million. The animal blood product market is experiencing a significant shift towards increased transparency, rigorous quality control, and comprehensive traceability. This trend is driven by various factors, including regulatory mandates, scientific research demands, and societal concerns for animal welfare. In the biopharmaceutical industry, where animal serum plays a crucial role in manufacturing life-saving therapies, the importance of a well-documented and traceable supply chain cannot be overstated. Regulatory bodies such as the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) enforce stringent Current Good Manufacturing Practice (cGMP) standards, requiring manufacturers to maintain complete control and documentation for all raw materials. This emphasis on traceability and quality control is essential for ensuring the scientific reproducibility and ethical sourcing of animal blood products.
Get more information on Animal Blood Product Market by requesting a sample report
The market is segmented based on
According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows:
However, the market also witnesses some limitations, which are as follows:
Rich Experience: 20+ years leading global market research, trusted insights across industries.
Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.
Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.
Market Scope |
|
Report Coverage |
Details |
Page number |
246 |
Base year |
2024 |
Historic period |
2019-2023 |
Forecast period |
2025-2029 |
Growth momentum & CAGR |
Accelerate at a CAGR of 7.3% |
Market growth 2025-2029 |
USD 1914.7 million |
Market structure |
fragmentation |
YoY growth 2024-2025(%) |
6.8 |
Key countries |
US, Germany, China, UK, Canada, India, France, Japan, Australia, and Brazil |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Find out which segment is leading the market by accessing the free PDF report
The Animal Blood Product Market encompasses the production and application of various animal blood components, including protein extraction methods and blood fractionation techniques. Blood-derived pharmaceuticals are manufactured through blood meal processing, which involves the characterization and quality assurance testing of blood product applications. Blood collection protocols ensure blood-borne pathogen control, while waste reduction strategies promote sustainable blood processing. Regulatory guidelines are strictly adhered to for blood product labeling, and processing equipment is utilized for optimization and compliance. Bioavailability enhancement and formulation development are key considerations, along with functional properties analysis, biochemical characterization, microbial contamination control, and sterilization validation methods.
The animal blood products market encompasses the production and research and development of blood meal protein, animal plasma fractionation, hemoglobin derivatives, and blood protein hydrolysate. These products fall under the broader umbrella of the global pharmaceuticals market, which includes manufacturers and providers of equipment, supplies, pharmaceuticals, biotechnology, and life sciences tools and services. The market's growth is driven by several factors, including the increasing global population aging, with one-quarter of the US population projected to be over 60 years old by 2050, and Europe reaching a similar population ratio by 2030. This demographic shift will lead to a higher demand for healthcare products and services, including animal blood derivatives used in pharmaceuticals and biotechnology applications.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted